The safety/tolerability of opicapone when used early in parkinson’s disease patients with levodopa-induced motor fluctuations: a post-hoc analysis of bipark-i and ii

HIGHLIGHTS

• who: José-Francisco Rocha from the University Hospital Fundación Jiménez Díaz, Spain have published the research: The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II, in the Journal: (JOURNAL)
• what: The authors have conducted additional post-hoc analyses to assess the safety/tolerability of OPC using the same approach. The methodology employed in this study has been described previously .

SUMMARY

Post-hoc analyses of the BIPARK-I and II trials . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.